| 4/2/2014 | SPRING meeting
Bid inhibits the Rip1-Mediated Necrotic Pathway | 9455 MRB IV | Patrice Wagner |
| 4/4/2014 | CRISPR Interest Group | MRBIII Room 3131 | None provided |
| 10/30/2014 | Flexner Discovery Lecture Series
CellNet: Enhancing Cellular Engineering Through Network Biology | 208 Light Hall | George Q. Daley, MD, PhD |
| 11/12/2014 | Beta Cell Interest Group (BIG) Seminar
“The Characterization of MafB in Adult β-cells" | 512 Light Hall | Holly Cyphert (Stein) |
| 4/2/2015 | Flexner Discovery Lecture Series
Human Obesity and Insulin Resistance: Lessons from the Extremes | 208 Light Hall | Sir Stephen O'Rahilly, MD, FRCP, FRCPI, FRCPath |
| 4/23/2015 | Flexner Discovery Lecture Series | 208 Light Hall | Roel Nusse, PhD |
| 10/19/2015 | VCSCB/CDB Seminar Series
"Overcoming Impediments to Cellular Reprogramming" | 1220 MRB III | Ken Zaret, Ph.D. |
| 12/2/2015 | SPRING Meeting
Reprogramming strategy to engineer a cardiac fate | 9455 MRB IV | Young-Jae Nam, M.D., Ph.D. |
| 1/21/2016 | Flexner Discovery Lecture Series
Opening Doors Worldwide through Medical Science | 208 Light Hall | Peter Agre, M.D. |
| 1/28/2016 | Flexner Discovery Lecture Series
Intention-to-Treat Analysis with Treatment Discontinuation and Missing Data in Clinical Trials | 208 Light Hall | Roderick J.A. Little, Ph.D. |
| 2/25/2016 | Flexner Discovery Lecture Series
The Essential Role of Bioinformatics in Exploring the World of Proteins and Characterizing the Human Proteome | 208 Light Hall | Gilbert S. Omenn, M.D., Ph.D. |
| 5/5/2016 | Flexner Discovery Lecture Series
Linking Metabolism to Stem Cell Maintenance | 208 Light Hall | Craig B. Thompson, M.D. |
| 3/20/2017 | VCSCB/CDB Seminar Series
Chemical control of endogenous stem cells for treatment of myelin disorders | 1220 MRB III | Paul Tesar, Ph.D. |
